State Street Corp Glaukos Corp Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Glaukos Corp stock. As of the latest transaction made, State Street Corp holds 2,063,399 shares of GKOS stock, worth $194 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,063,399

Previous 1,954,449 5.57%

Holding current value

$194 Million

Previous $255 Million 21.51%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $13.8 Million - $16.6 Million	108,950 Added 5.57%	2,063,399 $309 Million
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $11.1 Million - $13.3 Million	98,109 Added 5.29%	1,954,449 $255 Million
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $2.74 Million - $3.63 Million	30,630 Added 1.68%	1,856,340 $220 Million
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $672,243 - $847,607	8,799 Added 0.48%	1,825,710 $172 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $3.04 Million - $4.35 Million	51,104 Added 2.89%	1,816,911 $144 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $1.15 Million - $1.31 Million	-16,540 Reduced 0.93%	1,765,807 $133 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $1.43 Million - $2.24 Million	31,471 Added 1.8%	1,782,347 $127 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $1.96 Million - $2.34 Million	44,555 Added 2.61%	1,750,876 $87.7 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $430,610 - $609,204	10,549 Added 0.62%	1,706,321 $74.5 Million
Q3 2022 Nov 15, 2022	SELL	$46.84 - $58.49 $116,397 - $145,347	-2,485 Reduced 0.15%	1,695,772 $90.3 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $568,740 - $1.04 Million	16,315 Added 0.97%	1,698,257 $77.1 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $490,289 - $639,489	-11,060 Reduced 0.65%	1,681,942 $97.3 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $2.28 Million - $3.22 Million	56,547 Added 3.46%	1,693,002 $75.2 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $4.77 Million - $8.47 Million	100,524 Added 6.54%	1,636,455 $78.8 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $6.13 Million - $8.2 Million	83,953 Added 5.78%	1,535,931 $130 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $704,793 - $974,881	10,007 Added 0.69%	1,451,978 $122 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $649,098 - $999,001	13,274 Added 0.93%	1,441,971 $109 Million
Q3 2020 Nov 10, 2020	BUY	$37.23 - $50.97 $265,933 - $364,078	7,143 Added 0.5%	1,428,697 $70.7 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $2.81 Million - $4.57 Million	97,508 Added 7.36%	1,421,554 $54.6 Million
Q1 2020 May 11, 2020	BUY	$25.53 - $70.14 $33.8 Million - $92.9 Million	1,324,046 New	1,324,046 $40.9 Million

Others Institutions Holding GKOS

# of Institutions

344

Shares Held

48M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.49B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Glaukos Corp Transaction History